All Stories

  1. Plasmablastic lymphoma: current perspectives

    Article • Blood and Lymphatic Cancer Targets and Therapy, October 2018, Dove Medical Press

    Dr Andres Lopez, Pau Abrisqueta

  2. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group

    Article • British Journal of Haematology, December 2014, Wiley

    Dr Andres Lopez